Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19- A Cluster Randomized Controlled Trial (SHARP COVID-19 RCT)

NCT04342156 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT04342156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04342156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19- A Cluster Randomized Controlled Trial (SHARP COVID-19 RCT)
Lead sponsor
Tan Tock Seng Hospital
Phase
Phase 3
Overall status
Withdrawn
Start date
April 30, 2020
Completion date
October 31, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, hydroxychloroquine adverse reaction